Nicolas Leupin Novo Cure LTD (NVCR) insider trading activity

NVCR Quotes by TradingView

Nicolas Leupin is Chief Medical Officer of NovoCure Ltd. Currently has a direct ownership of 105,108 shares of NVCR, which is worth approximately $1.87 Million. The most recent transaction as insider was on Mar 04, 2025, when has been sold 54,975 shares (Ordinary Shares) at a price of $18.19 per share, resulting in proceeds of $999,995. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K
105.59% 3M change
105.59% 12M change
Total Value Held $1.87 Million

Nicolas Leupin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 04 2025
BUY
Grant, award, or other acquisition
$999,995 $18.19 p/Share
54,975 Added 34.34%
105,108 Ordinary Shares
Feb 27 2025
SELL
Open market or private sale
$20,057 $20.24 p/Share
991 Reduced 1.94%
50,133 Ordinary Shares
Feb 27 2024
BUY
Grant, award, or other acquisition
$833,321 $16.3 p/Share
51,124 Added 50.0%
51,124 Ordinary Shares
NL

Nicolas Leupin

Chief Medical Officer
Wayne, PA

Track Institutional and Insider Activities on NVCR

Follow NovoCure Ltd and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCR shares.

Notify only if

Insider Trading

Get notified when an Novo Cure LTD insider buys or sells NVCR shares.

Notify only if

News

Receive news related to NovoCure Ltd

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NVCR